ABIGAIL GRAEBER: Open Payments
NPI 1316358807 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$56,594 in 86 payments from 3 companies in 2025. Trend: 2023 $35,459 · 2024 $58,371 · 2025 $56,594
Speaker / faculty: $22,165Travel & lodging: $20,619Speaker / faculty: $9,213Consulting: $3,165Food & beverage: $1,432
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 40 | $35,543 |
| Exelixis Inc. | 45 | $21,023 |
| PFIZER INC. | 1 | $28 |
Products named: FRUZAQLA, CABOMETYX, INLYTA.
Industry payments across PA — which companies pay providers there.
